What it is and how it works
From the published literature on Melatonin; the papers are listed at the end. Research summary, not a recommendation.
What it is
Melatonin (N-acetyl-5-methoxytryptamine) is a small hormone made from serotonin, mainly by the pineal gland in the brain; it is an indoleamine, not a peptide. Its release rises in darkness and falls in light, signalling night-time to the body's clock. Supplements are almost always taken by mouth; supplier vials are an injectable form that is not an approved product, and nearly all clinical evidence comes from oral use, with intravenous melatonin studied only in research settings.
How it works
Melatonin acts on two receptors, MT1 and MT2, which are G protein-coupled receptors (proteins on the cell surface that relay a signal inside the cell); they are concentrated in the suprachiasmatic nucleus, the brain's master clock. Activation of MT1 is linked to reduced firing of the clock neurons and sleepiness, while MT2 helps shift the timing of the clock, which is why the time of day it is given changes its effect. Taken in the evening it shortens the time to fall asleep and can move the body clock earlier, which underlies its use for jet lag. Melatonin is cleared quickly, with a half-life of under an hour, and oral bioavailability was low (a few percent to about a third) in pharmacokinetic studies because the liver breaks much of it down on first pass. Prescription drugs that act on the same receptors (ramelteon, tasimelteon, agomelatine) were developed from this biology.
What it has been studied for
- Shortening time to fall asleep and improving sleep in primary sleep disorders (meta-analysis of randomized trials)
- Timing and dose of melatonin for sleep onset (dose-response meta-analysis of randomized trials)
- Preventing and treating jet lag (Cochrane review of randomized trials)
- Adverse events with melatonin use (systematic review)
- Oral versus intravenous pharmacokinetics (human crossover study)
- Accuracy of melatonin content in supplements (laboratory analysis)
Strength of the evidence
Human trialsRandomized trials and meta-analyses support modest benefits for sleep onset and jet lag with oral melatonin; a prolonged-release tablet is a licensed prescription medicine in the EU and UK, but no injectable melatonin is approved anywhere.
What the literature reports on safety
A systematic review found few adverse events, generally mild to moderate (daytime sleepiness, headache, dizziness), and none life-threatening, but noted a lack of long-term trials; the Cochrane jet-lag review flagged case reports of possible harm in people with epilepsy and an interaction with warfarin. In the US melatonin is sold as a dietary supplement, and a laboratory analysis found that most products did not contain their labelled amount and some contained serotonin; in the EU and UK it is prescription-only. Injectable melatonin vials sold outside pharmacies are not approved products, and their content and sterility are unverified.
Key papers
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective (opens in a new tab)
Review · Liu J, Clough SJ, et al. · Annual Review of Pharmacology and Toxicology (2016) · PMID 26514204
Reviewed how melatonin's two receptors regulate sleep and circadian rhythms and how drugs targeting them (prolonged-release melatonin, ramelteon, tasimelteon, agomelatine) were developed.
Meta-analysis: melatonin for the treatment of primary sleep disorders (opens in a new tab)
Review · Ferracioli-Oda E, Qawasmi A, et al. · PLoS One (2013) · PMID 23691095
Pooled randomized trials and found that melatonin shortened time to fall asleep, lengthened total sleep and improved sleep quality, with modest effects that did not fade over time.
Review · Cruz-Sanabria F, Bruno S, et al. · Journal of Pineal Research (2024) · PMID 38888087
Found that the effect on sleep onset depended on insomnia status and on how long before bedtime melatonin was taken, with earlier timing performing better.
Melatonin for preventing and treating jet lag (opens in a new tab)
Review · Herxheimer A, Petrie KJ · Cochrane Database of Systematic Reviews (2001) · PMID 11279722
Concluded from randomized trials that melatonin reduced jet lag after flights across five or more time zones, especially eastward, and that occasional short-term use appeared safe.
Review · Besag FMC, Vasey MJ, et al. · CNS Drugs (2019) · PMID 31722088
Found few, generally mild to moderate adverse events and none life-threatening, but too few long-term trials to judge continuous use.
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers (opens in a new tab)
Cohort study · Andersen LP, Werner MU, et al. · BMC Pharmacology and Toxicology (2016) · PMID 26893170
In a crossover study oral melatonin had only about 3% bioavailability compared with intravenous melatonin, and both routes were cleared within about an hour.
Lab (in vitro) · Erland LA, Saxena PK · Journal of Clinical Sleep Medicine (2017) · PMID 27855744
Of about 30 commercial supplements tested, more than 71% fell outside 10% of their label claim for melatonin and 26% contained serotonin.
Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), written 2026-11-06.
No sources yet
None of the three teachers' sources we have indexed discuss Melatonin yet. This page will fill in as sources are added.
Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.
Disclaimer: for research purposes only
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.